Works matching IS 14642662 AND DT 2015 AND VI 16 AND IP 2

Results: 8

Switching to emtricitabine, tenofovir and rilpivirine as single tablet regimen in virologically suppressed HIV-1-infected patients: a cohort study.

Published in:

HIV Medicine, 2015, v. 16, n. 2, p. 132, doi. 10.1111/hiv.12183

By:

Gantner, P;
Reinhart, S;
Partisani, M;
Baldeyrou, M;
Batard, M‐L;
Bernard‐Henry, C;
Cheneau, C;
Mautort, E;
Priester, M;
Fafi‐Kremer, S;
Muret, P;
Rey, D

Publication type:

Article

Factors responsible for incomplete linkage to care after HIV diagnosis: preliminary results from the Test and Keep in Care ( TAK) project.

Published in:

HIV Medicine, 2015, v. 16, n. 2, p. 88, doi. 10.1111/hiv.12175

By:

Ankiersztejn‐Bartczak, M;
Firląg‐Burkacka, E;
Czeszko‐Paprocka, H;
Kubicka, J;
Cybula, A;
Horban, A;
Kowalska, JD

Publication type:

Article

Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief ( PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.

Published in:

HIV Medicine, 2015, v. 16, n. 2, p. 95, doi. 10.1111/hiv.12177

By:

Crawford, KW;
Wakabi, S;
Magala, F;
Kibuuka, H;
Liu, M;
Hamm, TE

Publication type:

Article

Autoantibodies binding to ubiquitin-fold modifier-conjugating enzyme 1 ( Ufc1) and pleckstrin homology domain containing, family G (with Rho Gef domain) member 2 ( Plekhg2) are associated with mycobacterial infections.

Published in:

HIV Medicine, 2015, v. 16, n. 2, p. 114, doi. 10.1111/hiv.12194

By:

Tellermann, A;
Witte, T;
Lansche, C;
Stoll, M;
Schmidt, RE;
Baerlecken, NT

Publication type:

Article

Prevalence and correlates of obstructive sleep apnoea among patients with and without HIV infection.

Published in:

HIV Medicine, 2015, v. 16, n. 2, p. 105, doi. 10.1111/hiv.12182

By:

Kunisaki, KM;
Akgün, KM;
Fiellin, DA;
Gibert, CL;
Kim, JW;
Rimland, D;
Rodriguez‐Barradas, MC;
Yaggi, HK;
Crothers, K

Publication type:

Article

Predictors of unstructured antiretroviral treatment interruption and resumption among HIV-positive individuals in Canada.

Published in:

HIV Medicine, 2015, v. 16, n. 2, p. 76, doi. 10.1111/hiv.12173

By:

Samji, H;
Taha, TE;
Moore, D;
Burchell, AN;
Cescon, A;
Cooper, C;
Raboud, JM;
Klein, MB;
Loutfy, MR;
Machouf, N;
Tsoukas, CM;
Montaner, JSG;
Hogg, RS;
Aykroyd, G;
Balfour, L;
Bayoumi, A;
Burchell, A;
Cairney, J;
Calzavara, L;
Gough, K

Publication type:

Article

A randomized controlled trial of single-class maintenance therapy with abacavir/lamivudine/zidovudine after standard triple antiretroviral induction therapy: final 96-week results from the FREE study.

Published in:

HIV Medicine, 2015, v. 16, n. 2, p. 122, doi. 10.1111/hiv.12186

By:

Sprenger, HG;
Langebeek, N;
Mulder, PGH;
Napel, CHH;
Vriesendorp, R;
Hoepelman, AIM;
Legrand, JC;
Koopmans, PP;
Bravenboer, B;
Kate, RW;
Groeneveld, PHP;
Bierman, WFW;
Werf, TS;
Gisolf, EH;
Richter, C

Publication type:

Article

Is HIV post-exposure prophylaxis required following occupational exposure to a source patient who is virologically suppressed on antiretroviral therapy?

Published in:

2015

By:

Webster, DP

Publication type:

Editorial